Timeless Wealth is a leading Publisher of Investment-Opinion content supported by research. We utilize a mix of fundamental and behavioral analysis to uncover undervalued investment opportunities in the small cap sector. Follow us on twitter: https://twitter.com/#!/TimelessWealth
One of the first stocks Michael Goode looked to invest in when he first started investing in 2005 was a small company traded on the Pinksheets called US WindFarming. During his research, Michael found out that the CEO had previously been convicted of criminal stock fraud and had served time in jail for a scheme that purported to turn base metals into gold. Michael decided not to invest and six months later the SEC sued the company, alleging that all the press releases were fake and the company was a sham that existed for the sole purpose of selling shares to gullible investors in order to enrich the insiders.
Following that experience, Michael Goode became a bit of a cynic. While he called himself a value investor and even briefly ran a value investing newsletter, his true love was exposing fraud and failed businesses. At his blog GoodeValue.com, sometimes syndicated on SeekingAlpha.com, he blasted companies such as H2Diesel (later renamed New Generation Biofuels), Cytocore (later sued by the SEC), Remote MDX (later panned by Andrew Left of Citron Research and Carol Remond of Dow Jones Newswires), and Noble Roman’s Pizza (on which he was quoted in multiple articles in the Indianapolis Business Journal).
Michael Goode has continued to shine a light on stock promotions and the people behind them on his trading blog, GoodeTrades.com. He has blogged about lawsuits involving stock promoters (a couple more) and he has exposed the multiple websites used by certain stock promoters. He remains a full-time stock trader; you can see most of his trades on Profit.ly.
Michael Goode graduated from Earlham College in 2004 and obtained a Masters Degree in Cognitive Psychology in 2007, from Washington University in St. Louis. He is the managing member of MorningLightMountain LLC, the owner of GoodeTrades.com, OTCMicroCapResearch.com, and all other content he writes online. Michael Goode has never been charged with or convicted of any crime whatsoever.
I hold a Graduate Diploma in Applied Finance and Investment (similar to CFA), and a Graduate Diploma in Financial Planning.
I have 30 years of personal investing experience, and 17 years of professional financial advising experience, including trading experience at ETrade Australia, 6 years as a Senior Financial Planner at Commonwealth Bank of Australia and 10 years at High Net Worth Financial Advising. My business is a mix of young clients growing their wealth, pre-retirees, and retirees wanting income, some growth, and safety. As a global investor I use a macro thematic approach searching for good value and/or high growth. I search the globe for great investments with a focus on Asia, Emerging and Frontier Markets as well as "trend investing". I assess a countries demographics and growth potential. Some trends I currently follow include the rising Asian middle class, electric vehicles and the lithium/cobalt/graphite/nickel/copper miners, renewable energy, energy storage, smartphones, 3D printing, and personal robots.
I also love to invest in income producing investments that can grow over time and benefit from compounding....Included here are the near monopoly businesses such as the stock exchanges, and the high quality income producers.
I use direct shares, ETFs, mutual funds and some direct property investments.
Potential new clients can contact me via the private message section or via my HNW website, linked on my profile page. I have recently launched an international client service.
I am Wei. I began studying and investing stocks since 2007. I am a value-oriented investor. My portfolio is concentrated and usually has less than six holdings. I hold large percentage of cash since 2013. Currently, I focused more on some semiconductor stocks, oil-related stocks, and auto stocks.
- United States Naval Academy, BS. Varsity Baseball. 9 Years active duty U.S. Naval Officer.
- University of Michigan Ross School of Business, MBA, Investment Finance
- Assistant Professor, University of Michigan.
- 19 years investment industry experience with traditional and alternative firms: Equity Analyst, Portfolio Manager, National Sales Manager, SVP, CIO.
I'm an independent trader that takes a focus on micro to mid cap biotech and healthcare stocks. Having spent several years as an observer, I started trading in 2008, which has now become my primary source of income. I primarily track new developments and changes in the sector that have potential to cause dramatic growth opportunities.
VFC is just a guy with an opinion. VFC's Stock House brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - the biotech, pharmaceutical and healthcare sectors. VFC's Stock House provides research, informational and opinion-based coverage of various companies and stocks in multiple sectors.
The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies. Do not Buy/Sell based solely on VFC's ideas or opinions.
The goal of VFC's Stock House is to 'call it like I see it' - while bringing new ideas, companies, and discussions to the eyes of investors and readers. This is supposed to be fun and new investors should not invest with the idea that this will 'pay the bills' or with the belief that a stock will just keep going up. DD is paramount, but so is sticking to pre-conceived entry and exit strategies and not letting emotional trading get in the way.
Goals must be realistic, if it sounds far fetched, then it probably is. Let the big boys eat the cake - the small investor is just trying to pick up some crumbs, and there's nothing wrong with that!
Alan Brochstein, CFA, was the first investment professional to devote himself to sharing his observations about the cannabis industry from an investor's perspective publicly. He runs 420 Investor, a subscription-based due diligence platform for investors interested in the publicly-traded cannabis stocks and is also the founder of New Cannabis Ventures, a content aggregation site focused on investors and entrepreneurs in the cannabis industry.
Alan has worked in the securities industry since 1986, primarily with the responsibility for managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent research and consulting to registered investment advisors. In addition to advising several different hedge funds and investment managers, including Friedberg Investment Management, where he participated as a member of its investment management committee, Alan was also a senior analyst for the independent research firm Management CV. In 2008, he began providing a first-of-its-kind subscription-based service for individual investors, Invest By Model, which offered two different portfolios that investors could replicate in their own accounts for $20 per month. Alan also offered The Analytical Trader at Marketfy, where he used fundamental and technical analysis in a disciplined process to offer specific trade ideas geared towards swing traders.
Alan launched www.420Investor.com in late 2013 as the premier source of information for "Green Rush" investors seeking to capitalize on the proliferation of legalized medical and recreational cannabis. In March 2014, Alan, who is a member of the National Cannabis Industry Association, began to focus solely on the cannabis sector. He launched www.NewCannabisVentures.com in late 2015.
You can follow Alan on Facebook (www.facebook.com/420investor) or on Twitter (https://twitter.com/Invest420). Alan also moderates a large LinkedIn group focused on the cannabis industry, Cannabis Investors & Entrepreneurs (https://www.linkedin.com/groups/6523904)
I have 20 years of corporate communications experience in the Biotechnology and Pharmaceutical industries. I specialize in developing investor relations and public relations programs for private and newly public companies and include among my employers: Dura Pharmaceuticals, Sequenom, Inc., Discovery Partners International, Inovio Inc. (Genetronics), and Verus Pharmaceuticals.
MY WINNING RATIO on SA is 9/10 HISTORICALLY. Check my comments to verify.
------------------------------------------------------------------------------------------------------- I have been short and long stocks for 20 years as a fund mgr.
I am a swing style trader. Not an analyst nor an economist.
Its not about being right. Its about being profitable.
Editor of the How To Find Big Stocks Newsletter and the author of the How To Find Big Stocks Book.
I am constantly searching for investing trends and the companies with the competitive advantage in them.
An angel investor that is always looking for disruptive technologies and transformational changes.
I am a former technology entrepreneur with over 10 years of experience in trading equities, bonds and options. My investment style can be described as risk-averse opportunism. I believe that markets are rife with inefficiencies that can be exploited to generate outsize risk-adjusted returns.
I recently started a hedge fund that trades a data-driven quant strategy; we are not soliciting new investments at this time.